Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform AUSTIN, Texas – Feb 21st, 2026, Arna Pharma Inc. and Slate Run Pharmaceuticals announced they have signed an MOU to create a scaled-up U.S.-based specialty pharmaceutical joint venture focused on branded products, 505(b)(2) medicines, and